SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Podcast
Q3 Earnings Are Here, Novo Ditches Cell Therapy but Buys Akero, Gov’t Shutdown Hits CDC
Johnson & Johnson has yet to make a drug pricing deal with Trump; Novo makes more moves under new CEO; more than 1,000 laid off from CDC, though many immediately hired back; the BIOSECURE Act is back and more.
October 15, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration showing businessman trying to create his own road
Job search strategy
More Marathon Than Sprint: Getting Biopharma Jobs Often Takes 4+ Months, BioSpace Finds
Biopharma professionals aren’t typically hired right away, based on a BioSpace LinkedIn poll. In the past year, only about one-third of respondents found employment in three months or less. Several who did share their keys to success.
October 15, 2025
 · 
5 min read
 · 
Angela Gabriel
Illustration showing businessman relaxing while colleagues work
Career Advice
Job Hugging Won’t Save You: The Hidden Risk of Playing It Safe
In a volatile industry, staying put might seem like a smart bet, but job hugging can quietly erode your visibility, growth and future opportunities.
October 15, 2025
 · 
3 min read
 · 
Angela Justice
Woman Standing in Front of Mirror Looking goal Themselves as Successful concept vector illustrator stock illustration
C-suite
Biotech Leader Gujrathi Holds Up a Mirror for Other Women
Sheila Gujrathi, former CEO of Gossamer Bio, has written a new book that aims to offer the type of leadership manual she never had in her early career.
October 15, 2025
 · 
5 min read
 · 
Annalee Armstrong
illustration of man entering into a painting, surreal virtual meta verse concept
Immuno-oncology
Cartography Pushes Sequencing to the Limit To Find Bananas in 100 Apples
The startup, launched out of CEO Kevin Parker’s grad school idyll during the COVID lockdowns, is primed to find new targets where Big Pharmas won’t dare.
October 15, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
Digital illustration of the White House, a road leading to it, and a stars and stripes pattern in the sky.
Earnings
No Trump Drug Pricing Plan for J&J—Yet
Reporting third quarter earnings on Tuesday, Johnson & Johnson CEO Joaquin Duato said the healthcare giant has not yet secured a drug pricing deal with the White House, but discussions are ongoing.
October 14, 2025
 · 
3 min read
 · 
Annalee Armstrong
Robotic claw clutching a money stock illustration
Series B
Kailera Banks Massive $600M Raise for Phase III Obesity Study
Kailera’s lead asset, KAI-9531, elicited an average weight loss of more than 17% in a Phase III study in China. The biotech expects to launch a global late-stage program for the drug this year.
October 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Job Trends
Bonus Episode: Q3 2025 Job Market Update
In this bonus episode, BioSpace’s Vice President of Marketing ⁠Chantal Dresner⁠ and Careers Editor ⁠Angela Gabriel⁠ take a look at Q3 job market performance, layoffs and wider employment trends and policies impacting the biopharma workforce.
October 14, 2025
 · 
1 min read
 · 
Angela Gabriel
Cancer of the brain as tumor growth diagnosis and symptoms of gliomas meningiomas astrocytomas and oligodendrogliomas as diagnosis of symptoms as a paper sculpture.
Alzheimer’s disease
Roche, Lilly Win First FDA Nod for Alzheimer’s Blood Test for Primary Care Use
Elecsys’ approval could help boost the uptake of currently approved Alzheimer’s disease therapies, including Biogen’s Eisai-partnered Leqembi, with CEO Chris Viehbacher recently noting that such biomarker-based tests could “remove some of the bottlenecks” in uptake.
October 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS